Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-04-05 @ 11:17 AM
Study NCT ID:
NCT01193504
Status:
UNKNOWN
Last Update Posted:
2012-06-14
First Post:
2010-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Sponsor:
Innovative Medical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
25324
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. William Trattler
Old Organization:
The Center for Excellence in Eye care